BioCentury | Aug 19, 2019
Clinical News

Aug. 19 Clinical Quick Takes: Kalytera's cannabidiol shows promise for transplant, plus Abbisko and Brigham and Women's

...Kalytera's CBD prevents graft-vs-host disease Kalytera Therapeutics Inc. (TSX-V:KLY; OTCQB:KALTF) announced plans to start a Phase III registrational...
...and Karen Tkach Tuzman, Associate Editor ABSK021 Cannabidiol (CBD) oral solution (cannabidiol) Abbisko Therapeutics Co. Ltd. Brigham and Women's Hospital Kalytera Therapeutics Inc. Colony-stimulating...
BioCentury | Jul 3, 2018
Company News

Management tracks: Cigna, Novocure, Voyager

...as CFO. He was CFO at Bibby Offshore Holdings Ltd. (Aberdeen, U.K.). Cannabinoid therapeutics company Kalytera Therapeutics Inc....
BioCentury | Oct 11, 2017
Company News

Management tracks: Aerpio, Scancell, TCR2

...president and CEO. He was CEO of Thrasos Therapeutics Inc. (Montreal, Quebec). Cannabinoid therapeutics company Kalytera Therapeutics Inc....
BioCentury | Apr 7, 2017
Strategy

Pushing for progress in Prader-Willi

...CBD) oral solution Insys Therapeutics Inc. (NASDAQ:INSY) Hyperphagic behavior leading to obesity Phase II KAL671 Kalytera Therapeutics Inc....
BioCentury | Feb 24, 2017
Financial News

Kalytera Therapeutics completes private placement

...On Feb. 17, cannabinoid therapeutics company Kalytera Therapeutics Inc. (TSX-V:KALY) raised C$1.6 million ($1.2 million) through the sale...
...million). Clarus Securities, Haywood Securities and Canaccord Genuity were placement agents. Kalytera Therapeutics Inc. (TSX-V:KALY), Beverly, Mass. Alicia Parker Kalytera Therapeutics Inc....
Items per page:
1 - 5 of 5
BioCentury | Aug 19, 2019
Clinical News

Aug. 19 Clinical Quick Takes: Kalytera's cannabidiol shows promise for transplant, plus Abbisko and Brigham and Women's

...Kalytera's CBD prevents graft-vs-host disease Kalytera Therapeutics Inc. (TSX-V:KLY; OTCQB:KALTF) announced plans to start a Phase III registrational...
...and Karen Tkach Tuzman, Associate Editor ABSK021 Cannabidiol (CBD) oral solution (cannabidiol) Abbisko Therapeutics Co. Ltd. Brigham and Women's Hospital Kalytera Therapeutics Inc. Colony-stimulating...
BioCentury | Jul 3, 2018
Company News

Management tracks: Cigna, Novocure, Voyager

...as CFO. He was CFO at Bibby Offshore Holdings Ltd. (Aberdeen, U.K.). Cannabinoid therapeutics company Kalytera Therapeutics Inc....
BioCentury | Oct 11, 2017
Company News

Management tracks: Aerpio, Scancell, TCR2

...president and CEO. He was CEO of Thrasos Therapeutics Inc. (Montreal, Quebec). Cannabinoid therapeutics company Kalytera Therapeutics Inc....
BioCentury | Apr 7, 2017
Strategy

Pushing for progress in Prader-Willi

...CBD) oral solution Insys Therapeutics Inc. (NASDAQ:INSY) Hyperphagic behavior leading to obesity Phase II KAL671 Kalytera Therapeutics Inc....
BioCentury | Feb 24, 2017
Financial News

Kalytera Therapeutics completes private placement

...On Feb. 17, cannabinoid therapeutics company Kalytera Therapeutics Inc. (TSX-V:KALY) raised C$1.6 million ($1.2 million) through the sale...
...million). Clarus Securities, Haywood Securities and Canaccord Genuity were placement agents. Kalytera Therapeutics Inc. (TSX-V:KALY), Beverly, Mass. Alicia Parker Kalytera Therapeutics Inc....
Items per page:
1 - 5 of 5